Transforming growth factor-beta1 gene polymorphisms in Korean patients with pre-eclampsia

American Journal of Reproductive Immunology

Volumn 63, Issue 4, 2010, Pages 291-298

  Kim, Shin Young ^a   Lim, Ji Hyae ^a   Park, So Yeon ^a   Yang, Jae Hyug ^b   Kim, Moon Young ^b   Kim, Min Hyoung ^b   Ryu, Hyun Mee ^b  

^a Cheil General Hospital   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

Genetic polymorphism; Intrauterine growth restriction; Pre eclampsia; Transforming growth factor beta 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INTRAUTERINE GROWTH RETARDATION; KOREA; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ALLELE; ASIAN; GENETICS; PREGNANCY;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77951236101     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00795.x     Document Type: Article

References (35)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989, 161:1200-1204.
2. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991, 4:700-708.
3. Lim KH, Zhou Y, Janatpour M, McMaster M, Bass K, Chun SH, Fisher SJ. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997, 151:1809-1818.
4. Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992, 46:561-572.
5. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res 1995, 217:419-427.
6. Benian A, Madazli R, Aksu F, Uzun H, Aydin S. Plasma and placental levels of interleukin-10, transforming growth factor-beta1, and epithelial-cadherin in preeclampsia. Obstet Gynecol 2002, 100:327-331.
7. Muy-Rivera M, Sanchez SE, Vadachkoria S, Qiu C, Bazul V, Williams MA. Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. Am J Hypertens 2004, 17:334-338.
8. Enquobahrie DA, Williams MA, Qiu C, Woelk GB, Mahomed K. Maternal plasma transforming growth factor-beta1 concentrations in pre-eclamptic and normotensive pregnant Zimbabwean women. J Matern Fetal Neonatal Med 2005, 17:343-348.
9. Matsushita S, Narumiya H, Hirata M, Yabushita H, Noguchi M, Nakanishi M. Expression of matrix metalloproteinase (MMP), tissue inhibitor of etalloproteinase (TIMP), and transforming growth factor-beta1 (TGF-beta1) in human placenta during preeclampsia. Trophoblast Research 1999, 13:395-406.
10. Kim SJ, Glick A, Sporn MB, Roberts AB. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem 1989, 264:402-408.
11. Clark DA, Coker R. Transforming growth factor-beta (TGF-beta). Int J Biochem Cell Biol 1998, 30:293-298.
12. Watanabe Y, Kinoshita A, Yamada T, Ohta T, Kishino T, Matsumoto N, Ishikawa M, Niikawa N, Yoshiura K. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway. J Hum Genet 2002, 47:478-483.
13. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998, 66:1014-1020.
14. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999, 8:93-97.
15. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998, 13:1569-1576.
16. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kem{eth}!{eth} R, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003, 63:2610-2615.
17. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 2000, 97:3479-3484.
18. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000, 101:2783-2787.
19. Cambien F, Ricard S, Troesch A, Mallet C, Générénaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996, 28:881-887.
20. Rivera MA, Echegaray M, Rankinen T, Pérusse L, Rice T, Gagnon J, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. TGF-beta(1) gene-race interactions for resting and exercise blood pressure in the HERITAGE Family Study. J Appl Physiol 2001, 91:1808-1813.
21. Park HM. Korean Society of Obstetrics and Gynecology: Obstetrics 2007, 4th ed, Seoul, KoonJa
22. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, Heathcote K. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci 1998, 95:659-667.
23. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994, 101:669-674.
24. Brosens IA. The role of the uterine junctional zone in the pathogenesis of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1995, 63:199.
25. Hsuan JJ. Transforming growth factors beta. Br Med Bull 1989, 45:425-437.
26. Vuckovic M, Genbacev O, Kumar S. Immunohistochemical localisation of transforming growth factor-beta in first and third trimester human placenta. Pathobiology 1992, 60:149-151.
27. Walter P, Johnson AE. Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu Rev Cell Biol 1994, 10:87-119.
28. Hishida A, Iwata H, Hamajima N, Matsuo K, Mizutani M, Iwase T, Miura S, Emi N, Hirose K, Tajima K. Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer 2003, 10:63-69.
29. Li X, Yue ZC, Zhang YY, Bai J, Meng XN, Geng JS, Fu SB. Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer. J Clin Lab Anal 2008, 22:164-171.
30. Stanczuk GA, Mccoy MJ, Hutchinson IV, Sibanda EN. The genetic predisposition to produce high levels of TGF-beta1 impacts on the severity of eclampsia/pre-eclampsia. Acta Obstet Gynecol Scand 2007, 86:903-908.
31. de Lima TH, Sass N, Mattar R, Moron AF, Torloni MR, Franchim CS, Daher S. Cytokine gene polymorphisms in preeclampsia and eclampsia. Hypertens Res 2009, 32:565-569.
32. Stallmach T, Hebisch G, Joller-Jemelka HI, Orban P, Schwaller J, Engelmann M. Cytokine production and visualized effects in the feto-maternal unit. Quantitative and topographic data on cytokines during intrauterine disease. Lab Invest 1995, 73:384-392.
33. Djurovic S, Schjetlein R, Wisløff F, Haugen G, Husby H, Berg K. Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia. Clin Genet 1997, 52:371-376.
34. Todros T, Marzioni D, Lorenzi T, Piccoli E, Capparuccia L, Perugini V, Cardaropoli S, Romagnoli R, Gesuita R, Rolfo A, Paulesu L, Castellucci M. Evidence for a role of TGF-beta1 in the expression and regulation of alpha-SMA in fetal growth restricted placentae. Placenta 2007, 28:1123-1132.
35. Baştürk B, Yavaşçaoĝlu I, Vuruşkan H, Göral G, Oktay B, Oral HB. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Cytokine 2005, 30:41-45.